SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-032016
Filing Date
2023-06-29
Accepted
2023-06-29 06:01:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20009606x3_defa14a.htm DEFA14A 10292
2 ny20009606x3_img01.jpg GRAPHIC 37126
3 ny20009606x3_img02.jpg GRAPHIC 218675
4 ny20009606x3_img03.jpg GRAPHIC 37918
5 ny20009606x3_img04.jpg GRAPHIC 54515
6 ny20009606x3_img05.jpg GRAPHIC 83472
  Complete submission text file 0001140361-23-032016.txt   606071
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-31141 | Film No.: 231054126
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences